No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Pharming Group | 6-K: Report of foreign private issuer (related to financial reporting)
Pharming Group Commences Cash Offer to Acquire Abliva for $66.1 Million
Press Release: Pharming Announces Public Cash Offer to the Shareholders of Abliva AB
Analysts Offer Insights on Healthcare Companies: Pharming Group (OtherPHGUF) and Phreesia (PHR)
RBC Capital Remains a Buy on Pharming Group (PHGUF)
European Biotech Pharming Group Touts Positive Data From Pivotal Pediatric Study Of FDA-Approved Immune System Disorder Drug